Veterinary Medicines

MASTIVET ΕΝΕΣΙΜΟ ΕΝΑΙΩΡΗΜΑ

Authorised
  • Trueperella pyogenes, strain ATCC 9730, Inactivated
  • Escherichia coli (inactivated)
  • Staphylococcus aureus, Inactivated
  • STREPTOCOCCUS PYOGENES INACTIVATED BACTERIA
  • Streptococcus uberis, Inactivated
  • Streptococcus dysgalactiae subsp. dysgalactiae, Inactivated
  • Streptococcus agalactiae, Inactivated

Product identification

Medicine name:
MASTIVET ΕΝΕΣΙΜΟ ΕΝΑΙΩΡΗΜΑ
Active substance:
  • Trueperella pyogenes, strain ATCC 9730, Inactivated
  • Escherichia coli (inactivated)
  • Staphylococcus aureus, Inactivated
  • STREPTOCOCCUS PYOGENES INACTIVATED BACTERIA
  • Streptococcus uberis, Inactivated
  • Streptococcus dysgalactiae subsp. dysgalactiae, Inactivated
  • Streptococcus agalactiae, Inactivated
Target species:
  • Cattle
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Trueperella pyogenes, strain ATCC 9730, Inactivated
    1000000000.00
    Colony forming unit
    /
    1.00
    millilitre(s)
  • Escherichia coli (inactivated)
    1800000000.00
    Colony forming unit
    /
    1.00
    millilitre(s)
  • Staphylococcus aureus, Inactivated
    1000000000.00
    Colony forming unit
    /
    1.00
    millilitre(s)
  • STREPTOCOCCUS PYOGENES INACTIVATED BACTERIA
    300000000.00
    Colony forming unit
    /
    1.00
    millilitre(s)
  • Streptococcus uberis, Inactivated
    300000000.00
    Colony forming unit
    /
    1.00
    millilitre(s)
  • Streptococcus dysgalactiae subsp. dysgalactiae, Inactivated
    300000000.00
    Colony forming unit
    /
    1.00
    millilitre(s)
  • Streptococcus agalactiae, Inactivated
    900000000.00
    Colony forming unit
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Cattle
      • Not applicable
        no withdrawal period
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI02AB
Authorisation status:
  • Valid
Authorised in:
  • Greece
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Anafasis Limited
Marketing authorisation date:
Manufacturing sites for batch release:
  • Laboratorios Ovejero S.A.U.
Responsible authority:
  • National Organization For Medicines
Authorisation number:
  • 88483/14-12-2015/K-0185601
Date of authorisation status change: